ACC 2022

Highlighted Original Research

POISE-3: Tranexamic acid for non-cardiac surgery

Presented By

Prof. Philip Devereaux; Dr Maura Marcucci, McMaster University, Canada

Trial

Phase 3, POISE-3

Conference

ACC 2022

15 June, 2022 15:34

Treating chronic mild hypertension during pregnancy leads to better outcomes

Presented By

Prof. Alan Tita, University of Alabama, USA

Trial

CHAP

Conference

ACC 2022

15 June, 2022 15:28

New VOYAGER PAD data: Should patients with both PAD and CKD get rivaroxaban?

Presented By

Dr Mark Svet, University of Colorado, USA

Trial

VOYAGER-PAD

Conference

ACC 2022

15 June, 2022 15:24

Alirocumab significantly reduces high-risk coronary plaques

Presented By

Prof. Lorenz Räber, Bern University Hospital, Switzerland

Trial

Phase 3, PACMAN-AMI

Conference

ACC 2022

15 June, 2022 15:20

Aggressive warming during non-cardiac surgery does not improve outcomes

Presented By

Prof. Daniel Sessler, Cleveland Clinic, USA

Trial

PROTECT

Conference

ACC 2022

15 June, 2022 15:15

Heart Failure and Cardiomyopathy

DIAMOND trial: Patiromer lowers risk of severe hyperkalaemia

Presented By

Prof. Javed Butler, University of Mississippi, MS, USA

Trial

Phase 3, DIAMOND

Conference

ACC 2022

15 June, 2022 15:12

Replacing septal reduction therapy with mavacamten for HCM

Presented By

Prof. Milind Desai, Cleveland Clinic, USA

Trial

Phase 3, VALOR-HCM

Conference

ACC 2022

15 June, 2022 15:08

Surprise outcome for SODIUM-HF

Presented By

Prof. Justin Ezekowitz, University of Alberta, Canada

Trial

Phase 3, SODIUM-HF

Conference

ACC 2022

15 June, 2022 15:03

Sotagliflozin SCORED MACE benefit

Presented By

Prof. Deepak Bhatt, Brigham and Women's Hospital, USA

Trial

Phase 3, SCORED

Conference

ACC 2022

15 June, 2022 14:57

Omecamtiv mecarbil does not impact exercise capacity of patients with HFrEF

Presented By

Prof. Michael Felker, Duke Clinical Research Institute, USA

Trial

Phase 3, METEORIC-HF

Conference

ACC 2022

15 June, 2022 14:50

Symptomatic obstructive hypertrophic cardiomyopathy: long-term mavacamten control

Presented By

Prof. Florian Rader, Cedars-Sinai Medical Center, CA, USA

Trial

MALVA-LTE

Conference

ACC 2022

15 June, 2022 14:47

Interventional and Structural Cardiology

COMPLETE revascularisation improves angina-related QoL

Presented By

Prof. Shamir Mehta, McMaster University, Canada

Trial

COMPLETE

Conference

ACC 2022

15 June, 2022 14:24

Plot twist for negative FAME 3 results: early QoL benefits of PCI

Presented By

Dr Frederik Zimmermann, Catharina Hospital, the Netherlands

Trial

FAME 3

Conference

ACC 2022

15 June, 2022 14:19

1-year CLASP TR results support tricuspid regurgitation repair

Presented By

Prof. Adam Greenbaum, Emory University School of Medicine, USA

Trial

CLASP TR

Conference

ACC 2022

15 June, 2022 14:14

Head-to-head: post-TAVR edoxaban not better than DAPT

Presented By

Prof. Duk-Woo Park, Asan Medical Center, Korea

Trial

Phase 4, ADAPT-TAVR

Conference

ACC 2022

15 June, 2022 14:09

Chocolate Touch vs Lutonix catheters

Presented By

Prof. Mehdi Shishehbor, Harrington Heart & Vascular Institute, USA

Trial

Chocolate Touch

Conference

ACC 2021

15 June, 2022 13:53

No FLAVOUR difference between FFR and IVUS for PCI guidance

Presented By

Prof. Bon-Kwon Koo, Seoul National University College of Medicine, Korea

Trial

FLAVOUR

Conference

ACC 2022

15 June, 2022 13:49

Myocardial Infarction

Prevention

PACIFIC-AF: Low bleeding rates for asundexian in atrial fibrillation

Presented By

Prof. Manesh Patel, Duke University School of Medicine, USA

Trial

Phase 2, PACIFIC-AF

Conference

ACC 2022

15 June, 2022 13:31

RCT-IVVE trial: Do HF patients benefit from annual flu shots?

Presented By

Prof. Mark Loeb, McMaster University, Canada

Trial

Phase 4, RCT-IVVE

Conference

ACC 2022

15 June, 2022 13:26

TRANSLATE-TIMI 70: Primary endpoint met but safety concerns for vupanorsen

Presented By

Dr Brian Bergmark, Brigham and Women’s Hospital, USA

Trial

Phase 2, TRANSLATE-TIMI 70

Conference

ACC 2022

15 June, 2022 13:21

Lipoprotein(a) slashed by 98% in APOLLO trial

Presented By

Prof. Steven Nissen, Cleveland Clinic, USA

Trial

Phase 1, APOLLO

Conference

ACC 2022

15 June, 2022 13:16

Dietary intervention from your supermarket

Presented By

Prof. Dylan Steen, University of Cincinnati, OH, USA

Trial

SuperWIN

Conference

ACC 2022

15 June, 2022 13:05